Key Points • Targeted sequencing of dysplastic cells and blasts at diagnosis identifies evolutionary patterns from dysplasia to the onset of AML.• Patients with AML may present different clonal involvement… Click to show full abstract
Key Points • Targeted sequencing of dysplastic cells and blasts at diagnosis identifies evolutionary patterns from dysplasia to the onset of AML.• Patients with AML may present different clonal involvement in dysplastic myelo-erythropoiesis, leukemic transformation, and chemoresistance.
               
Click one of the above tabs to view related content.